KOMIPHARM is a biopharmaceutical venture company focusing on the development of innovative new drugs for humans.


KOMIPHARM pharmaceutical division consists of professional researchers who have an in-depth experience in developing a variety of pharmaceuticals.  Our vision is to discover innovative medicine not only for domestic but also for the worldwide market.  With accumulated expertise and know-how, we are progressing forward.  We have been collaborating with several medical schools, hospitals and research institutes around the world, and together building a huge R&D ecosystem.


KOMIPHARM was established in 1972 and has grown to Market Capitalisation of (MIL) 1,195,386 Korean Won (1 Billion USD) in 2020.